Yong Zhang
GE Healthcare
3 Papers
25 Citations
Yong Zhang is an academic researcher from GE Healthcare. The author has contributed to research in topics: Hepatic stellate cell & Carcinoma. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ3 for staging liver fibrosis in rat model
TL;DR: Molecular MRI of integrin αvβ3 expressed on activated HSCs by using RGD-USPIO may distinguish different liver fibrotic stages in CCl4 rat model and shows promising to noninvasively monitor the progression of the liver fibrosis and therapeutic response to antifibrotic treatment.
Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging for Monitoring the Early Response to ZD6474 from Nasopharyngeal Carcinoma in Nude Mouse.
Yanfen Cui,Caiyuan Zhang,Xiaoming Li,Huanhuan Liu,Bing Yin,Tian-Yong Xu,Yong Zhang,Dengbin Wang +7 more
TL;DR: This study supports that IVIM DWI is sensitive to detect the ZD6474-induced changes in NPC in nude mouse and the f parameter could predict early response to anti-angiogenic treatment.
Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles.
Yanfen Cui,Caiyuan Zhang,Ran Luo,Huanhuan Liu,Zhongyang Zhang,Tian-Yong Xu,Yong Zhang,Dengbin Wang +7 more
TL;DR: It is demonstrated that the magnetic resonance molecular nanoprobes, RGD-PAA-USPIOs, allow noninvasive in vivo imaging of tumor angiogenesis and assessment of the early response to antiangiogenic treatment in NPC xenograft model, favoring its potential clinical translation.